Warming the lungs

"Warming the lungs" (Wen Fei) is a traditional therapeutic principle in Chinese medicine used to treat respiratory disorders characterized by "cold-fluid" or "cold-phlegm" accumulation, which modernly maps to conditions like chronic obstructive pulmonary disease (COPD) and bronchial asthma [4, 7]. It is not a specific molecular target, such as a single receptor or enzyme, but rather a holistic clinical strategy involving the use of acrid and warming medicinal herbs [6, 13]. These herbal interventions, such as the Xiao Qing Long decoction, are believed to restore pulmonary function by expelling "cold" pathogens and promoting the dispersal of lung Qi [7, 9]. Research into the molecular mechanisms of these treatments suggests they exert their effects by inhibiting pro-inflammatory pathways like NF-κB and PI3K/AKT, while also regulating the AMPK signaling pathway to maintain energy homeostasis [1, 2, 5]. Common bioactive components of these "warming" agents include gingerol from Zingiber officinale and asarinin from Asarum, which have shown affinity for targets like EGFR and TNF-alpha in network pharmacology studies [4, 8, 15]. Overall, while the phrase describes a potent therapeutic approach for inflammatory lung diseases, it refers to a multi-target physiological action rather than a discrete biochemical entity.

Other names

Wen FeiWarming the lung and resolving fluidWarming the lung to dissolve phlegmWen Fei Hua Yin

Therapies categorized under this principle act by modulating multiple signaling pathways rather than a single target. Key mechanisms include the inhibition of the NF-κB and MAPK pathways to reduce the secretion of inflammatory cytokines (TNF-α, IL-6), the regulation of the PI3K/AKT/mTOR axis to suppress airway remodeling, and the activation of the AMPK pathway to improve lipid metabolism and energy balance in lung tissues [1, 4, 7, 15].